Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Citivas Injection

Prescription Icon
Prescription Required

Marketer

Invision Medi Sciences Pvt Ltd

Salt Composition

Citicoline (500mg)

Overview Citivas Injection

Neuro-Guard injection treats stroke, head trauma, Alzheimer's disease, and Parkinson's-related dementia by safeguarding and repairing brain cells, thus enhancing cognitive function. Administered intravenously by a healthcare professional only – particularly when oral intake is impossible – the dosage and duration should strictly follow medical guidance. Missed doses should be taken promptly upon recollection. Potential side effects, including hypotension, gastrointestinal distress (pain and diarrhea), cardiac arrhythmias, skin rashes, sleep disturbances, and worsening or onset of paresthesia in affected limbs, are possible. Injection site reactions (pain, redness, swelling) are common but generally transient. Persistent or bothersome side effects warrant medical consultation. Prior to treatment, disclose any kidney issues, seizure history (epilepsy), pregnancy, breastfeeding, or pregnancy plans. Dosage is tailored to age and condition; complete medication disclosure to your physician is crucial.

Uses of Citivas Injection

Managing Stroke|Treating Head Trauma|Alzheimer's Disease Management|Dementia Care in Parkinson's Disease

Major Benefits of Citivas Injection:

This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.

Common Side effects of Citivas Injection:

  • Injection site reactions (pain, swelling, redness)
  • Decreased blood pressure
  • Arrhythmia (irregular heartbeats)
  • Stomach pain
  • Diarrhea
  • Insomnia (difficulty in sleeping)
  • Rash
  • Peripheral neuropathy (tingling and numbness of feet and hand)

How to use Citivas Injection:

This medication will be administered by your healthcare provider; self-medication is strictly prohibited.

How Citivas Injection works:

Citivas Injection safeguards nerve tissue. It fosters nerve cell health, shielding them from injury and enhancing their viability through the generation of key neurochemicals such as phosphatidylcholine and acetylcholine. Additionally, it mitigates the accumulation of free fatty acids at nerve injury sites.

SAFETY ADVICE

AlcoholAlcoholCONSULT YOUR DOCTOR

Alcohol consumption alongside Citivas Injection may pose unknown risks. Seek medical advice before combining them.

PregnancyPregnancyCONSULT YOUR DOCTOR

Data on the administration of Citivas Injection to pregnant individuals is lacking. Seek medical advice from your physician.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Data on the use of Citivas Injection while breastfeeding is lacking. Seek medical advice from your physician.

DrivingDrivingCONSULT YOUR DOCTOR

The impact of Citivas Injection on driving ability is undetermined. Refrain from driving if experiencing symptoms impairing concentration or reaction time.

KidneyKidneyCAUTION

Exercise caution when administering Citivas Injection to individuals with impaired renal function. Dosage modification for Citivas Injection might be necessary. Physician consultation is advised.

LiverLiverCONSULT YOUR DOCTOR

Insufficient data exists regarding Citivas Injection's use in individuals with hepatic impairment. Physician consultation is advised.

What if you forget to take Citivas Injection :

NA

Facts to Know About Citivas Injection

LabelValue
Chemical Type Pyrimidine nucleotide diphosphate
Developing Habits No.
Type of Treatment Neuroscience, Central Nervous System
Behavior Class Cognitive enhancer

FAQs on Citivas Injection

Citivas Injection delivers choline, a vital nutrient naturally occurring in the body. It safeguards brain nerve cells from damage and aids their repair, thus enhancing learning, memory, and cognitive function in individuals with Alzheimer's disease.
While research on alcohol's interaction with Citivas Injection is lacking, given its use in treating serious conditions like stroke, Alzheimer's, Parkinson's disease, head injuries, and age-related memory loss, alcohol consumption should be avoided.
Citivas Injection is unsuitable for students. Studies confirm its efficacy only for age-related memory loss, memory impairment following stroke, and Alzheimer's disease. Its use in children is unsupported by data.
For stroke patients with blood clots, oral Citivas Injection may facilitate full recovery within three months. Intravenous administration of Citivas Injection within 12 hours of stroke onset, or daily for seven days post-stroke, may accelerate recovery.
Citivas Injection
78
MRP 90
13% off